Bipolar disorder affects between two and four percent of the population worldwide, yet research has been tragically underfunded relative to other mental health conditions. Bipolar illness is one of the most life-threatening of all serious mental disorders.
Although most sufferers struggle to maintain stable work and social lives, those living with bipolar disorder have paradoxically made outsized contributions to science, academia, government and the arts. Though bipolar disorder is traditionally viewed as a life-long illness, the Baszucki family witnessed first-hand that full recovery is possible using evidence-based metabolic interventions proven to stabilize brain networks.
We partner with principal investigators and their teams, as well as other funders, to advance basic and translational bipolar research. In addition, we invest in individuals, institutions and companies developing precision mental health solutions for bipolar and beyond.
On September 12, 2022, the Baszucki, Dauten, and Brin families joined with the Milken Institute to launch BD²: Breakthrough Discoveries for thriving with Bipolar Disorder. BD² is a global platform coordinating science across disciplines and national borders to tackle this complex and still poorly understood disorder.
Read more
In addition to ketogenic metabolic intervention research, we have been supporting cutting-edge research on mood disorders for several years. To accelerate our giving in bipolar disorder, specifically, the Milken Institute assisted us in running a competitive program in 2021 which resulted in 45 research grants to advance bipolar therapeutic discovery and translational research.
Read moreHighlighted Grants
